Penserra Capital Management’s Charles River Laboratories CRL Stock Holding History

Penserra Capital Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,412	Closed	-$533K	–	1078
2025 Q3	$533K	Buy	+3,412	New	+$542K	0.01%	558
2025 Q1	–	Sell	-130	Closed	-$23K	–	1063
2024 Q4	$23K	Buy	+130	New	+$25K	﹤0.01%	1006
2024 Q1	–	Sell	-235	Closed	-$55K	–	1281
2023 Q4	$55K	Sell	235 -49	-17%	-$9.64K	﹤0.01%	983
2023 Q3	$55K	Sell	284 -47	-14%	-$9.65K	﹤0.01%	982
2023 Q2	$69K	Buy	+331	New	+$65.9K	﹤0.01%	1005
2021 Q4	–	Sell	-1,539	Closed	-$635K	–	1402
2021 Q3	$635K	Sell	1,539 -4,384	-74%	-$1.82M	0.01%	453
2021 Q2	$2.19M	Buy	5,923 +1,425	+32%	+$476K	0.04%	331
2021 Q1	$1.3M	Buy	4,498 +2,872	+177%	+$798K	0.02%	338
2020 Q4	$406K	Buy	+1,626	New	+$387K	0.01%	401

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Penserra Capital Management's CRL Position: Q4 2025 in Review

Penserra Capital Management sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 3,412 shares — an estimated $533K sold.

Penserra Capital Management first reported a position in CRL in Q4 2020 and held it in 9 quarters. The position peaked at $2.19M in Q2 2021. 582 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

Penserra Capital Management reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
Penserra Capital Management sold 3,412 Charles River Laboratories shares in Q4 2025, an estimated $533K.
Penserra Capital Management first reported a position in Charles River Laboratories in Q4 2020 and held it in 9 quarters.
Penserra Capital Management's Charles River Laboratories position peaked at $2.19M in Q2 2021.
582 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on Penserra Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.